Giuseppe Filomeni




  • Name: Giuseppe Filomeni
  • Specialized in: Redox signaling, metabolism, aging, cancer.
  • Email:

Honors and Fellowships (societies, boards, awards (etc etc)

2004 Young Investigator Award, the Society for Free Radical Research, Lodz (PL)

2013-present Editor of Oxidative Medicine and Cellular Longevity

2011 Lead Guest Editor of International Journal of Cell Biology – Special Issue on “Redox Bioenergetics Liaison in Cancer and Neurodegeneration

2013 Lead Guest Editor of Frontiers in Oncology for the Research Topic “Redox and Metabolic Circuits in Cancer

2013-present Reviewer for funding agencies: Parkinson’s UK and World-Wide Cancer Research (UK), Croatian Science Foundation (HR), The Italian Ministry of University and Research (I), The Austrian Science Fund – FWF (AU).


Main applicant:

2010 – Young Italian Researchers Grant, Proposal n. GR-2008-1138121 – Italian Ministry

of Health.

2012 – MFAG – 2011, proposal n. 11452 – Italian Association for Cancer Research (AIRC).

2014 – Danish Cancer Society Scientific Committee (KBVU), Proposal n. R72-A4647 – Danish Cancer Society (DK).

2016 – Danish Cancer Society Scientific Committee (KBVU), Proposal n. R146-A9414 – Danish Cancer Society (DK).

2017 – Investigator Grant IG 2017, Proposal n. 20719 – Italian Association for Cancer Research (AIRC).

2017 – ISCRA – CINECA HPC system, Project n. IsC55.


2014 – Uncovering Excellence Grant, Proposal “MDESMPLAT” – University of Tor Vergata.

2016 – National Institute for Insurance against Accidents at Work (INAIL), Proposal n. DCR 131.

Professional Memberships

2012 The European Cell Death Organization;

2007 The Biochemical Society;

2004 The Society of Free Radical Research;

Research field

The main focus of our laboratory has been always directed to the characterization of new redox signaling pathways governing cell life and death, and the identification of the molecular players underneath. During the last ten years we have contributed to clarify the role of the mitogen activated protein kinase (MAPK) super family and the AMP-dependent protein kinase (AMPK) in the cytotoxicity of several redox-active compounds (of new synthesis or natural-derived), which exert anti-tumor activity. 

By tradition, we have deep expertise of all the biochemical processes underlying cell metabolism and bio-energetics, and our main value is to combine this skill with state-of-the-art technology and protocols of molecular and cellular biology. By means of such a synergy and through the collaborations with worldwide renowned scientists, we have more recently unveiled the role of autophagy and mitochondrial function and dynamics in different aspects of cancer biology and aging. In particular, we have focused on the enzyme S-nitrosoglutathione reductase (GSNOR) and its role in human pathophysiology, namely in neuromuscular diseases, cancer, and aging. We have discovered that any deficiencies of GSNOR deeply affects skeletal muscle physiology and is tightly associated with malignancy through the selective S-nitrosylation of key proteins and enzymes underlying mitochondrial morphology and quality control, rather than cell adhesion and phospho-signaling. We have also provided evidence that GSNOR silencing is a physiological event caused by epigenetic modifications of DNA, which takes place during life span and profoundly contributes to mammalian cell senescence and aging.

15 selected Publications of the last 10 years

*, first author

**, last/corresponding author

  • S. Cardaci, G. Filomeni*, G. Rotilio, M.R. Ciriolo (2008) “Reactive oxygen species mediates p53 activation and apoptosis induced by sodium nitroprusside in SH-SY5Y cells.” Mol Pharmacol. 74, 1234-1245. 

  • G. Filomeni*, S. Piccirillo, I. Graziani, S. Cardaci, A.M. Da Costa Ferreira, G. Rotilio, M.R. Ciriolo (2009) “A novel isatin-Schiff base copper(II) complex acts as delocalized lipophilic cation, yields widespread mitochondrial oxidative damage and induces AMP-activated protein kinase-dependent apoptosis.” Carcinogenesis. 30, 1115-1124. 

  • S. Piccirillo, G. Filomeni*, B. Brune, G. Rotilio, M.R. Ciriolo (2009) “Redox mechanisms involved in the selective activation of Nrf2-mediated resistance versus p53-dependent apoptosis in adenocarcinoma gastric cells.” J Biol Chem. 284, 27721-27733. 

  • G. Filomeni*, E. Desideri, S. Cardaci, I. Graziani, S. Piccirillo, G. Rotilio, M.R. Ciriolo (2010) “Carcinoma cells activate AMP-activated protein kinase-dependent autophagy as survival response to kaempferol-mediated energetic impairment.” Autophagy. 6, 202-216. 

  • S. Cardaci, G. Filomeni*, G. Rotilio, M.R. Ciriolo (2010) “p38MAPK/p53 signaling axis mediates neuronal apoptosis in response to tetrahydrobiopterin-induced oxidative stress and glucose uptake inhibition: implication for neurodegeneration.” Biochem J. 430, 439-451. 

  • G. Filomeni**, E. Desideri, S. Cardaci, G. Rotilio, M.R. Ciriolo (2010) “Under the ROS…Thiol network is the principal suspect for autophagy commitment.” Autophagy. 6, 999-1005. 

  • G. Filomeni*, S. Cardaci, A.M. Da Costa Ferreira, G. Rotilio, M.R. Ciriolo (2011) “Metabolic oxidative stress elicited by the copper(II) complex [Cu(isaepy)2] triggers apoptosis in SH-SY5Y cells through the induction of AMP-activated protein kinase/p38MAPK/p53 signalling axis.” Biochem J. 437, 443-453. 

  • G. Filomeni*, I. Graziani, D. De Zio, L. Dini, D. Centonze, G. Rotilio, M.R. Ciriolo (2012) “Neuroprotection of kaempferol by autophagy in models of rotenone-mediated acute toxicity: possible implications for Parkinson’s disease.” Neurobiol Aging. 33, 767-785. 

  • S. Cardaci, G. Filomeni**, M.R. Ciriolo (2012) “Redox implications of AMPK-mediated signal transduction beyond the energetic clues.” J Cell Sci. 125, 2115-2125. 

  • C. Montagna, G. Di Giacomo, S. Rizza, S. Cardaci, E. Ferraro, P. Grumati, D. De Zio, E. Maiani, C. Muscoli, F. Lauro, S. Ilari, S. Bernardini, S. Cannata, C. Gargioli, M.R. Ciriolo, F. Cecconi, P. Bonaldo, G. Filomeni** (2014) “S-nitrosoglutathione reductase deficiency-induced S-nitrosylation results in neuromuscular dysfunction.” Antioxid Redox Signal. 21, 570-587. 

  • G. Filomeni**, D. De Zio, F. Cecconi (2014) “Oxidative stress and autophagy: the clash between damage and metabolic needs.” Cell Death Differ. 22, 377-388. 

  • S. Rizza, C. Cirotti, C. Montagna, S. Cardaci, C. Consales, M. Cozzolino, M.T. Carrí, F. Cecconi, G. Filomeni** (2015) “S-nitrosoglutathione reductase plays opposite roles in SH-SY5Y models of Parkinson’s disease and amyotrophic lateral sclerosis.” Mediators Inflamm. 2015:536238. 

  • S. Rizza, C. Montagna, S. Cardaci, E. Maiani, G. Di Giacomo, V. Sanchez-Quiles, B. Blagoev, A. Rasola, D. De Zio, J.S. Stamler, F. Cecconi, G. Filomeni** (2016) “S-nitrosylation of the mitochondrial chaperone TRAP1 sensitizes hepatocellular carcinoma cells to succinate dehydrogenase-targeting drugs.” Cancer Res. 76, 4170-4182. 

  • S. Rizza, G. Filomeni** (2017) “Chronicles of a reductase: Biochemistry, genetics and physiopathological role of GSNOR.” Free Radic Biol Med. 110, 19-30.

  • S. Rizza , S. Cardaci , C. Montagna , G. Di Giacomo , D. De Zio , M. Bordi , E. Maiani , S. Campello , A. Borreca , A.A. Puca , J.S. Stamler , F. Cecconi , G. Filomeni** (2018) “S-nitrosylation drives cellular senescence and aging in mammals by controlling mitochondrial dynamics and mitophagyProc Natl Acad Sci USA (In press)



Education & Training

  • 2007-present

    Researcher, Dept. of Biology, University of Rome Tor Vergata (I).

  • 2013-present

    Head of the Redox Signaling and Oxidative Stress Research Group, Danish Cancer Society Research Center (DK)

  • 2010-2013

    Group Leader, Research Center IRCCS San Raffaele Pisana, Rome, (I);

  • 2007

    Research fellow for the ‘Italian Association for Cancer Research’ at Dept. of Biology, University of Rome Tor Vergata (I).

  • 2004-2007

    Young Researcher for the “Funding for Base Research Investments” of the Ministry of University and Research (FIRB – MIUR) at Dept. of Biology, University of Rome Tor Vergata (I).

  • 2003

    Post-Doctoral fellow, Dept. of Biomedical Sciences University of Chieti G. D’Annunzio (I).

  • 2002

    Research collaborator, Institute for Cancer Research ‘IFO - Regina Elena’ of Rome (I).

  • 2002

    Ph.D. in Molecular and Cellular Biology, Dept. of Biology, University of Rome Tor Vergata (I).

  • 1997

    D.Sc. Biological Science Degree, University of Rome Tor Vergata (I).